If you've had eczema for years and feel like you've tried everything — every prescription cream, every steroid, every "gentle" moisturizer that wasn't gentle enough — you're not alone. A lot of adults in South Florida reach a point where the standard treatments just don't cut it anymore. The flares keep coming. The itch disrupts sleep. The skin never fully heals between outbreaks.
That's exactly the kind of situation where biologic treatments have started to make a real difference.
Biologics are a newer class of medications that work differently from topical creams or oral steroids. Instead of suppressing the immune system broadly, they target specific pathways in the body that drive eczema inflammation. The result, for many patients with moderate to severe eczema, is a level of control they hadn't experienced before — sometimes after years of struggling with treatments that only partially worked.
The word "biologic" can sound intimidating, but it's worth demystifying. Unlike traditional medications that are made from chemicals, biologics are derived from living cells. They're designed to block specific proteins or receptors in the immune system — the ones responsible for triggering the kind of inflammation that causes eczema symptoms.
For eczema specifically, the biologics that have shown the most clinical success target pathways involving interleukin-4 (IL-4) and interleukin-13 (IL-13), two signaling molecules that play a central role in the inflammatory process behind atopic dermatitis. When those signals are blocked, the cycle of inflammation that leads to itching, redness, and skin breakdown is interrupted at a much more fundamental level than a topical steroid can achieve.
If you've heard the name Dupixent in a commercial or from another patient, that's the brand name for dupilumab — currently the most widely used and extensively studied biologic for atopic dermatitis in adults. It was approved by the FDA for moderate-to-severe eczema in adults in 2017, and since then it has been studied in tens of thousands of patients with results that have genuinely shifted the way dermatologists approach hard-to-treat eczema.
Dupilumab is given as a subcutaneous injection — meaning it goes under the skin rather than into a vein. Most patients start with an initial loading dose and then inject every two weeks, either self-administering at home after instruction or coming in for injections at their dermatologist's office. The medication is manufactured by Sanofi and Regeneron Pharmaceuticals. If you've ever searched where is Dupixent made, the answer is that it's produced through biological manufacturing processes at facilities managed by those companies — a far cry from how a topical cream is compounded.
In clinical trials, a significant percentage of patients treated with dupilumab saw 75% or greater improvement in their eczema severity scores within 16 weeks. That's not a minor bump in symptom relief — for people who have struggled with daily itching and widespread skin involvement, that kind of improvement is life-changing.
Common side effects include injection site reactions and, in some patients, conjunctivitis (eye irritation or redness). Serious side effects are uncommon, and the medication does not carry the immunosuppression risks associated with systemic steroids taken long term.
Dupilumab was the first, but it's no longer the only option. The FDA has since approved additional biologics and a related class of medications called JAK inhibitors for adults with moderate-to-severe atopic dermatitis. These include:
Having multiple options matters because not every patient responds the same way to every drug. What works well for one person may not be the right fit for another, and having a knowledgeable dermatologist evaluate your specific history, skin type, and lifestyle is essential to choosing the right path.
Biologics aren't the first stop for every eczema patient. They're generally considered when:
If you've been managing eczema with a rotating set of creams and steroid courses and you feel like you're just treading water, that's worth a direct conversation with a dermatologist. The goal of biologic therapy isn't just to reduce flares — it's to get eczema to a point where it stops running your life.
Living in Miami-Dade, Broward, or Palm Beach County means your skin faces a specific set of pressures year-round. The heat and humidity that define South Florida can trigger eczema flares in ways that patients who moved here from cooler climates didn't anticipate. As we've covered before in our post on why humidity and heat in South Florida trigger eczema flare-ups, the combination of sweating, air conditioning, and outdoor exposure creates a near-constant challenge for skin that's already prone to inflammation.
For adults with severe or chronic eczema, those environmental pressures mean that symptom management requires more than seasonal adjustments — it often requires a treatment approach that addresses the immune system directly, not just the surface of the skin.
There's also the practical reality of how heat interacts with skin that's actively inflamed. Sun and heat can worsen inflammatory skin conditions in general, and for eczema patients, sweat trapped against compromised skin can be a constant source of irritation. Getting inflammation under control at the root level isn't just about comfort — it's about giving the skin barrier a real chance to recover.
A conversation about biologics starts with a full picture of where you are. At Dermatology Experts, Dr. Ayar will want to understand how long you've been dealing with eczema, what you've already tried, how your symptoms affect your daily life, and whether there are any other health factors — including other medications or conditions — that might affect which treatment is the right choice.
If a biologic is recommended, you'll receive clear guidance on how the medication works, what to expect during the first few months, how to administer injections if you'll be doing that at home, and what to watch for in terms of side effects. Nothing about the process will be rushed or left unexplained. Patients at our Miami, Parkland, and Tamarac offices consistently say they feel informed and cared for — not hurried out the door with a prescription and a pamphlet.
Insurance coverage for biologics can be complex, and the team is experienced in helping patients understand their options, including manufacturer patient assistance programs that can significantly reduce out-of-pocket costs for qualifying patients.
One thing worth reframing: biologic therapy for eczema isn't something you graduate to after suffering long enough. It's a legitimate treatment option for the right patients, and delaying it out of hesitation about trying something new can mean years of unnecessary discomfort and skin damage.
The skin barrier breaks down with repeated eczema flares. Skin that's chronically compromised is harder to restore, and the longer inflammation is left unchecked, the more cumulative damage accumulates. Getting ahead of that with an effective treatment isn't aggressive — it's practical.
If you've been searching for how to treat severe eczema and feel like you've hit a wall, biologic therapy may be the conversation you've been waiting to have. And if you've been putting it off because you weren't sure where to go or who to ask — that's exactly what we're here for.
Dermatology Experts sees patients at three convenient South Florida locations — Miami, Parkland, and Tamarac — and Dr. Ayar's team is experienced in evaluating and managing moderate-to-severe eczema in adults of all skin types and backgrounds. Whether you're coming in for the first time or have been managing eczema for decades and are ready to explore what's new, you'll get a straight answer and a plan you actually understand.
Call us or request an appointment online. If there's a better option for your skin, we'll tell you plainly — and we'll help you get there.